Steffen Pietzke's Net Worth
$5.9 Million
Who is Steffen Pietzke?
Steffen Pietzke has an estimated net worth of $5.9 Million. This is based on reported shares across multiple companies, which include Enovix Corp, ALX ONCOLOGY HOLDINGS INC, Tricida, Inc., and PDL BIOPHARMA, INC..
SEC CIK
Steffen Pietzke's CIK is 0001647008
Past Insider Trading and Trends
2021 was Steffen Pietzke's most active year for acquiring shares with 5 total transactions. Steffen Pietzke's most active month to acquire stocks was the month of June. 2023 was Steffen Pietzke's most active year for disposing of shares, totalling 17 transactions. Steffen Pietzke's most active month to dispose stocks was the month of November. 2021 saw Steffen Pietzke paying a total of $306,500.00 for 738,164 shares, this is the most they've acquired in one year. In 2022 Steffen Pietzke cashed out on 37,730 shares for a total of $470,416.64, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Enovix Corp (ENVX) Snapshot price: $9.86
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.22% | -1.36K |
$18.63 | -$25,355.43 | 621.38K |
Jul 6
| |||
Form 4
| -0.24% | -1.52K |
$13.63 | -$20,744.86 | 622.75K |
Jun 22
| |||
Form 4
| -0.06% | -387.00 |
$13.73 | -$5,313.51 | 624.27K |
Jun 10
| |||
Form 4
| +0.39% | 2.43K |
$13.61 | -$10,643.02 | 624.65K |
Jun 7
| |||
Form 4
| -0.84% | -5.30K |
$13.72 | -$72,674.84 | 622.23K |
Jun 6
| |||
Form 4
| -0.24% | -1.52K |
$12.09 | -$18,400.98 | 627.52K |
May 22
| |||
Form 4
| -0.06% | -387.00 |
$13.02 | -$5,038.74 | 629.05K |
May 10
| |||
Form 4
| -0.12% | -757.00 |
$12.64 | -$9,568.48 | 629.43K |
May 6
| |||
Form 4
| -0.24% | -1.52K |
$12.59 | -$19,161.98 | 630.19K |
Apr 22
| |||
Form 4
| +13.75% | 76.16K |
—
|
—
| 630.1K |
Apr 10
| |||
Form 4
| -0.14% | -757.00 |
$12.31 | -$9,318.67 | 553.94K |
Apr 6
| |||
Form 4
| -0.27% | -1.52K |
$11.01 | -$16,757.22 | 554.69K |
Mar 22
| |||
Form 4
| -0.14% | -757.00 |
$9.87 | -$7,471.59 | 556.22K |
Mar 6
| |||
Form 4
| -0.27% | -1.52K |
$8.28 | -$12,602.16 | 556.97K |
Feb 22
| |||
Form 4/A
| -0.68% | -3.84K |
$8.45 | -$32,422.65 | 558.5K |
Feb 14
| |||
Form 4
| +5.42% | 28.89K |
—
|
—
| 562.33K |
Feb 14
| |||
Form 4
| -0.17% | -922.00 |
$8.97 | -$8,270.34 | 533.44K |
Feb 6
| |||
Form 4
| -0.35% | -1.85K |
$7.96 | -$14,757.84 | 534.36K |
Jan 22
| |||
Form 4
| -0.17% | -922.00 |
$8.05 | -$7,422.10 | 536.22K |
Jan 6
| |||
Form 4
| -0.46% | -2.46K |
$10.80 | -$26,568.00 | 537.14K |
Dec 22
| |||
Form 4
| -0.23% | -1.22K |
$11.73 | -$14,345.79 | 539.6K |
Dec 6
| |||
Form 4
| +217.38% | 370.42K |
$12.45 | -$368,320.80 | 540.82K |
Nov 22
| |||
Form 4
| -0.44% | -757.00 |
$10.74 | -$8,130.18 | 170.4K |
Nov 6
| |||
Form 4
| -1.31% | -2.27K |
$17.68 | -$40,158.85 | 171.16K |
Aug 6 - Oct 6
| |||
Form 4
| -0.43% | -741.00 |
$8.68 | -$6,431.88 | 173.43K |
Jul 6
| |||
Form 4
| +595.83% | 149.14K |
—
|
—
| 174.17K |
Jun 6
| |||
Form 4/A
| -2.70% | -694.00 |
$9.31 | -$6,461.14 | 25.03K |
May 20
| |||
Form 4
| +11.85% | 2.73K |
—
|
—
| 25.73K |
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 18
| |||
Form 4
| +4.55% | 1K |
$11.50 | $11,500.00 | 23K |
Dec 14
| |||
Form 4
| +1,000.00% | 20K |
$14.75 | $295,000.00 | 22K |
Aug 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ALX ONCOLOGY HOLDINGS INC (ALXO) Snapshot price: $15.02
VP Fin & Chief Acct Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3K |
$19.00 | $57,000.00 | 3K |
Jul 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Tricida, Inc. No price found
VP Fin & Chief Acct Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 20
| |||
Form 4
|
∞
| 10.53K |
$19.00 | $200,013.00 | 10.53K |
Jul 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PDL BIOPHARMA, INC. No price found
VP, Finance and CAO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.80% | -5.51K |
—
|
—
| 139.59K |
Dec 15
| |||
Form 4
| +208.32% | 98.04K |
$2.04 | $199,999.56 | 145.1K |
Mar 4
| |||
Form 4
| -1.39% | -663.00 |
—
|
—
| 47.06K |
Dec 13
| |||
Form 4
| +187.68% | 31.14K |
$3.22 | $100,254.70 | 47.72K |
Jan 26
| |||
Form 4
|
∞
| 20.59K |
$3.64 | $74,931.13 | 20.59K |
Dec 7
| |||
Form 4
| +12.48% | 1.84K |
$4.95 | $9,112.95 | 16.59K |
Sep 29
| |||
Form 4
|
∞
| 14.75K |
$6.18 | $91,142.64 | 14.75K |
Jul 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||